PMCB earnings: real EPS beat/miss history, analyst consensus Hold, P/E -0.59. Updated 2026-07-23.
PharmaCyte Biotech (PMCB) Research Hub
PharmaCyte Biotech (PMCB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.4502 USD (-5.28%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.59, market cap 0.00B. This hub links to the full technical, earnings and options research available for PMCB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.4502 USD (-5.28%) |
| 52-week range | 0.4302 USD – 0.84 USD |
| Trend regime | Range |
| 14-day RSI | 8.2 (Oversold) |
| Trailing P/E | -0.59 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for PMCB
Covered Call on PMCB: how it works, illustrative setup around the real 0.4502 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PMCB: how it works, illustrative setup around the real 0.4502 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PMCB: how it works, illustrative setup around the real 0.4502 USD price, max profit/loss, breakeven and when to use it. Educational.
PMCB technical analysis: range, last 0.4502 USD, RSI 8.2, 52w range 0.4302 USD–0.84 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PMCB in?
PharmaCyte Biotech (PMCB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PMCB in an uptrend or downtrend?
As of 2026-09-11, PMCB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PMCB's trailing P/E ratio?
PMCB's trailing P/E is -0.59, with a market cap of 0.00B. See the earnings research page for full valuation detail.